Antioxidants Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy

類似資料

• Bortezomib Does Not Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
  著者:: Körner, Zandra, 等
  出版事項: (2016)
• Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study
  著者:: Fontes-Oliveira, Cibely C., 等
  出版事項: (2018)
• Exploratory Profiling of Urine MicroRNAs in the dy(2J)/dy(2J) Mouse Model of LAMA2-CMD: Relation to Disease Progression
  著者:: Moreira Soares Oliveira, Bernardo, 等
  出版事項: (2018)
• Early skeletal muscle pathology and disease progress in the dy(3K)/dy(3K) mouse model of congenital muscular dystrophy with laminin α2 chain-deficiency
  著者:: Gawlik, Kinga I., 等
  出版事項: (2019)
• Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD
  著者:: Moreira Soares Oliveira, Bernardo, 等
  出版事項: (2017)